A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

Summary

The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.

Timeline

Start

2021-11-08

Primary completion

2023-11-08

Completion

2024-10-07

Outcome

Missed primary endpoint

release “PASI Score의 변화량을 각각의 위약군(고용량 N=7, 저용량 N=8)의 동일한 변화량과 비교했을 때 통계적으로 유의하게 차이를 보이지 않았다” kobiolabs.com ↗

Drugs

Indications